Bio-Rad Laboratories Class B
BIO.B
8 hedge funds and large institutions have $935K invested in Bio-Rad Laboratories Class B in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.
14% more funds holding
Funds holding: 7 → 8 (+1)
0% less ownership
Funds ownership: 0.07% → 0.07% (-0%)
25% less capital invested
Capital invested by funds: $1.25M → $935K (-$316K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MG
Mather Group
Chicago,
Illinois
|
+$303 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CL
CSS LLC
Chicago,
Illinois
|
-$60.7K |
| 2 |
Morgan Stanley
New York
|
-$3.64K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $439K | -$60.7K | -200 | -11% |
|
|
BSW
2
Buckingham Strategic Wealth
Clayton,
Missouri
| $203K | – | – | – |
|
|
3
Morgan Stanley
New York
| $190K | -$3.64K | -12 | -2% |
|
4
Wells Fargo
San Francisco,
California
| $48.2K | – | – | – |
|
|
WT
5
Whittier Trust
South Pasadena,
California
| $45.4K | – | – | – |
|
6
Jones Financial Companies
Des Peres,
Missouri
| $9.05K | – | – | – |
|
|
JFA
7
JNBA Financial Advisors
Bloomington,
Minnesota
| $534 | – | – | – |
|
|
MG
8
Mather Group
Chicago,
Illinois
| $341 | +$303 | +1 | New |
|
BIO.B Hedge Fund Activity: Q2 2024 in Review
8 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q2 2024, worth a combined $935K — down 25% from $1.25M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BIO.B positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Mather Group, opening a new position worth an estimated $303. The largest seller was CSS LLC, cutting an estimated $60.7K.
- 8 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q2 2024, up from 7 in Q1 2024.
- Funds reported $935K of Bio-Rad Laboratories Class B stock for Q2 2024, down 25% quarter-over-quarter.
- 1 fund opened new Bio-Rad Laboratories Class B positions in Q2 2024 and 0 closed out, a net change of +1 holder.
- The largest Bio-Rad Laboratories Class B buyer in Q2 2024 was Mather Group, an estimated $303 added.
- The largest Bio-Rad Laboratories Class B seller in Q2 2024 was CSS LLC, an estimated $60.7K sold.
Based on aggregated 13F filings for Q2 2024.